MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-07-2025
National Research Corporation Operating Cash Flow 2011-2026 | NRC
Annual Operating Cash Flow National Research Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 38.1 M | 36.3 M | 46.3 M | 40.6 M | 40.9 M | 39.8 M | 28.1 M | 26.8 M | 21.9 M | 26.2 M | 19.3 M | 19.1 M | 18.5 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 46.3 M | 18.5 M | 30.9 M |
Quarterly Operating Cash Flow National Research Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 6.65 M | - | - | - | 12 M | - | - | - | 7.75 M | - | 28.2 M | - | 8.29 M | - | 34.3 M | - | 14.4 M | - | 24.4 M | 13.9 M | 5.52 M | - | 29 M | 16.1 M | 7.3 M | - | 25.9 M | 18.4 M | 8.23 M | - | 21.5 M | 10.6 M | 8.14 M | - | 18 M | 11.2 M | 4.37 M | - | 14.8 M | 9.23 M | 1.58 M | - | 20.6 M | 11.4 M | 5.16 M | - | 15.3 M | 5.97 M | 3.1 M | - | 13.6 M | 7.8 M | 2.08 M | - | 14.4 M | 8.26 M | 3.88 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 34.3 M | 1.58 M | 12.7 M |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
-32.2 M | - | -6.19 % | $ 10.5 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
-478 M | $ 38.83 | 14.0 % | $ 442 M |  China |
 |
Brainsway Ltd.
BWAY
|
884 K | $ 23.3 | -0.34 % | $ 99.4 M |  Israel |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
64.9 M | $ 39.38 | -0.03 % | $ 1.09 B | USA |
 |
BioNano Genomics
BNGO
|
-68.9 M | $ 1.26 | -2.69 % | $ 1.6 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-8 M | - | - | $ 9.42 M | Israel |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
Exact Sciences Corporation
EXAS
|
211 M | $ 102.49 | 0.14 % | $ 19 B | USA |
 |
Co-Diagnostics
CODX
|
-22.1 M | - | - | $ 79.8 M | USA |
 |
Danaher Corporation
DHR
|
6.69 B | $ 222.92 | 1.85 % | $ 163 B | USA |
 |
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B |  Australia |
 |
Guardant Health
GH
|
-240 M | $ 114.77 | 0.64 % | $ 14.1 B | USA |
 |
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | China |
 |
DexCom
DXCM
|
748 M | $ 72.79 | -0.34 % | $ 28.1 B | USA |
 |
CareDx, Inc
CDNA
|
-18.4 M | $ 20.29 | -1.27 % | $ 1.09 B | USA |
 |
Celcuity
CELC
|
-83.5 M | $ 111.76 | 2.14 % | $ 4.41 B | USA |
 |
DarioHealth Corp.
DRIO
|
-30.4 M | $ 10.74 | 7.19 % | $ 305 M | Israel |
 |
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
21.1 M | $ 26.0 | -0.76 % | $ 786 M | USA |
 |
Lantheus Holdings
LNTH
|
545 M | $ 66.88 | -0.07 % | $ 4.63 B | USA |
 |
Medpace Holdings
MEDP
|
609 M | $ 585.24 | 0.47 % | $ 18.1 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | USA |
 |
IDEXX Laboratories
IDXX
|
929 M | $ 636.25 | -5.1 % | $ 52.5 B | USA |
 |
NeoGenomics
NEO
|
7.02 M | $ 12.25 | 1.53 % | $ 1.55 B | USA |
 |
Illumina
ILMN
|
837 M | $ 140.65 | -2.87 % | $ 22.4 B | USA |
 |
QIAGEN N.V.
QGEN
|
674 M | - | - | $ 10.6 B |  Niderland |
 |
IQVIA Holdings
IQV
|
2.72 B | $ 230.93 | 0.34 % | $ 41.9 B | USA |
 |
Charles River Laboratories International
CRL
|
735 M | $ 212.06 | 0.7 % | $ 10.9 B | USA |
 |
Precipio
PRPO
|
-3.56 M | $ 24.75 | 0.9 % | $ 32.1 M | USA |
 |
Personalis
PSNL
|
-45.2 M | $ 9.28 | -0.96 % | $ 550 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.33 B | $ 184.48 | -1.33 % | $ 20.5 B | USA |
|
Biodesix
BDSX
|
-48.6 M | $ 10.24 | 0.69 % | $ 1.33 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.59 B | $ 269.19 | -0.86 % | $ 22.6 B | USA |
 |
ICON Public Limited Company
ICLR
|
1.29 B | $ 176.3 | -2.19 % | $ 14.5 B |  Irlanda |
 |
Agilent Technologies
A
|
1.48 B | $ 134.7 | 0.62 % | $ 40.9 B | USA |
 |
Biomerica
BMRA
|
-3.84 M | $ 2.39 | 0.63 % | $ 5.49 M | USA |
 |
OpGen
OPGN
|
-4.87 M | - | -16.95 % | $ 1.54 M | USA |
 |
Bioventus
BVS
|
15.3 M | $ 8.23 | 3.78 % | $ 516 M | USA |